ArticleFrontiers in cardiovascular medicine2022

Selexipag-based triple combination therapy improves prognosis in Chinese pulmonary arterial hypertension patients.

Xiaopei Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.